Biontech SE
Veridion Score
Composite trend over time
Why is BNTX moving today?
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for BNTX.
Continue the BNTX research trail.
BNTX insider activity
Biontech SE
No multi-insider buying cluster in the last 90 days
Net selling: -$5.5M across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
| Filing date | Trade date | Insider | Title | Type | Price | Qty | Owned | Value | Receipt |
|---|---|---|---|---|---|---|---|---|---|
| 2026-04-23 | 2026-04-22 | Poetting Sierk | Chief Operating Officer | sell | $110.56 | 50,000 | 399,387 | $5.5M | SEC Form 4 |
BNTX contract awards, year to date.
Public federal awards linked to this ticker.
BNTX lobbying filings, year to date.
Registered lobbying filings matched to Biontech SE.